Postoperative Crohn’s disease: how can we prevent it?

References

• Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut54(2), 237–241 (2005).
   PubMed Web of Science ®Google Scholar
• Bennell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann. Surg.231(1), 38–45 (2000).
   PubMedGoogle Scholar
• Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology99(4), 956–983 (1990).
   PubMed Web of Science ®Google Scholar
• Olaison G, Smedh K, Sjodahl R. Natural course of Crohn’s disease after ileocolic resection: endoscopically visualized ileal ulcers preceding symptoms. Gut33(3), 331–335 (1991).
   Google Scholar
• Chardavoyne R, Flint GW, Pollack S, Wise L. Factors affecting recurrence following resection for Crohn’s disease. Dis. Colon Rectum29(8), 495–502 (1986).
   PubMed Web of Science ®Google Scholar
• Pascua M, Su C, Lewis JD, Brensinger C, Lichtenstein GR. Meta-analysis: factors predicting postoperative recurrence with placebo therapy in patients with Crohn’s disease. Aliment. Pharmacol. Ther.28(5), 545–556 (2008).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut25(6), 665–672 (1984).
   PubMed Web of Science ®Google Scholar
• Landsend E, Johnson E, Johannessen HO, Carlsen E. Long-term outcome after intestinal resection for Crohn’s disease. Scand. J. Gastroenterol.41(10), 1204–1208 (2006).
   PubMed Web of Science ®Google Scholar
• Lock MR, Farmer RG, Fazio VW et al. Recurrence and reoperation for Crohn’s disease. N. Engl. J. Med.304(26), 1586–1588 (1982).
   Google Scholar
• Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology99(4), 956–963 (1990).
   PubMed Web of Science ®Google Scholar
• Blum E, Katz JA. Postoperative therapy for Crohn’s disease. Inflamm. Bowel Dis.15(3), 463–472 (2009).
   PubMed Web of Science ®Google Scholar
• Yamamoto T. Factors affecting recurrence after surgery for Crohn’s disease. World J. Gastroenterology11(26), 3971–3979 (2005).
   PubMed Web of Science ®Google Scholar
• Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology110(2), 424–431 (1996).
   PubMed Web of Science ®Google Scholar
• Avidan B, Sakhnini E, Lahat A et al. Risk factors regarding the need for a second operation in patients with Crohn’s disease. Digestion72(4), 248–253 (2005).
   PubMed Web of Science ®Google Scholar
• Greenstein AJ, Lachman P, Sachar DB et al. Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut29(5), 588–592 (1988).
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn’s disease. Gastroenterology115(2), 259–267 (1998).
   PubMed Web of Science ®Google Scholar
• McLeod RS, Wolff BG, Ross S, Parkes R, McKenzie M. Recurrence of Crohn’s disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis. Colon Rectum52(5), 919–927 (2009).
   PubMed Web of Science ®Google Scholar
• Munoz-Juarez M, Yamamoto T, Wolff BG, Keighley MR. Wide-lumen stapled anastomosis vs. conventional end-to end anastomosis in the treatment of Crohn’s disease. Dis. Colon Rectum44(1), 20–25 (2001).
   PubMedGoogle Scholar
• Caprilli R, Corrao G, Taddei G, Tonelli F, Torchio P, Viscido A. Prognostic factors for postoperative recurrence of Crohn’s disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis. Colon Rectum39(3), 335–341 (1996).
   PubMed Web of Science ®Google Scholar
• Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies. Int. J. Colorectal Dis.23(12), 1213–1221 (2008).
   PubMed Web of Science ®Google Scholar
• Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Interventions for prevention of postoperative recurrence of Crohn’s disease. Cochrane Database Syst. Rev.7(4), CD006873 (2009).
   Google Scholar
• Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology108(6), 1617–1621 (1995).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Van Assache G, Vermeire S et al. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double blind, placebo-controlled trial. Gastroenterology128(4), 856–861 (2005).
   PubMed Web of Science ®Google Scholar
• Ardizzone S, Maconi G, Sampietro GM et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. Gastroenterology127(3), 730–740 (2004).
   PubMed Web of Science ®Google Scholar
• Hanauer SB, Korelitz BI, Rutgeerts P et al. Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology127(3), 723–729 (2004).
   PubMed Web of Science ®Google Scholar
• D’Haens G, Vermeire S, Van Assche G et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial. Gastroenterology125(4), 1123–1129 (2008).
   Google Scholar
• Peyrin-Biroulet L, Deltenre P, Ardizzone S et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Am. J. Gastroenterology104(8), 2089–2096 (2009).
   PubMed Web of Science ®Google Scholar
• Regueiro M, Schraut W, Baidoo L et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology136(2), 441–450 (2009).
   PubMed Web of Science ®Google Scholar
• Regueiro M, Schraut WH, Baidoo L et al. Two year follow-up of patients enrolled in the randomized controlled trial (RCT) of infliximab (IFX) for prevention of recurrent Crohn’s disease (CD). Gastroenterology136(Suppl. 1), A-522 (2009).
   Google Scholar
• Sorrentino D, Terrosu G, Avellini C. Maiero S. Infliximab with low-dose methotrexate for prevention of postoperative Crohn’s disease recurrence of ileocolonic Crohn’s disease. Arch. Intern. Med.167(16), 1804–1807 (2007).
   PubMedGoogle Scholar
• Calabrese E, Petruzziello C, Inali S et al. Severity of postoperative recurrence in Crohn’s disease: correlation between endoscopic and sonographic findings. Inflamm. Bowel Dis.15(11), 1635–1642 (2009).
   PubMed Web of Science ®Google Scholar
• Lamb CA, Mohiuddin MK, Gicquel J et al. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn’s disease. Br. J. Surg.96(6), 663–674 (2009).
   PubMed Web of Science ®Google Scholar
• Sailer J, Peloschek P, Reinisch W, Vogelsang H, Turetschek K, Schima W. Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur. Radiol.18(11), 2512–2521 (2008).
   PubMed Web of Science ®Google Scholar
• Castiglione F, Bucci L, Pesce G et al. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn’s disease. Inflamm. Bowel Dis.14(9), 1240–1245 (2008).
   PubMed Web of Science ®Google Scholar